For the Inventor, By the Inventor

Enter assignee name

Stockholm, Sweden

Bioarctic Neuroscience Ab

USPTO Granted Patents = 16

CIPO Patents = 14

EPO Patents = 5

Forward Citations = 159

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Lars Lannfelt (14 out of 17 patents)

Pär Gellerfors (8 out of 10 patents)

Alex Kasrayan (4 out of 4 patents)

4. Eva Nordström (4 out of 4 patents)

5. Monica Ekberg (4 out of 4 patents)

6. Valentina Screpanti Sundquist (4 out of 4 patents)

7. Mats Holmquist (4 out of 4 patents)

8. Joakim Bergström (2 out of 2 patents)

9. Martin Ingelsson (2 out of 2 patents)

10. Dag Sehlin (2 out of 3 patents)

11. Frida Ekholm Pettersson (2 out of 2 patents)

12. Hillevi Englund (2 out of 2 patents)

13. Camilla Nilsberth (2 out of 3 patents)

14. Anita Campbell (2 out of 2 patents)

15. Jan Näslund (2 out of 3 patents)

16 patents: Sort by Forward Citations

1. 9895234 - Spinal cord devices and methods for promoting axonal regeneration (2018-02-20),

2. 9573994 - Aβ protofibril binding antibodies (2017-02-21),

3. 9315569 - Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders (2016-04-19),

4. 9084832 - Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies (2015-07-21),

5. 9034334 - Protofibril selective antibodies and the use thereof (2015-05-19),

6. 8999936 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof (2015-04-07),

7. 8968734 - Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies (2015-03-03),

8. 8859501 - Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies (2014-10-14),

9. 8809506 - Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders (2014-08-19),

10. 8632776 - Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies (2014-01-21),

11. 8409575 - Antibodies specific for amyloid beta protofibril (2013-04-02),

12. 8404459 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof (2013-03-26),

13. 8106164 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof (2012-01-31),

14. 8025878 - Protofibril selective antibodies and the use thereof (2011-09-27),

15. 7709695 - Transgenic mouse expressing arctic mutation E693G (2010-05-04),

BioArctic is a Swedish research-intensive biopharmaceutical company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. With an innovative pipeline based on scientific excellence, BioArctic aims to improve the lives of patients and become a leader in the field of neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#51 in Stockholm

#379 in Sweden

#36,634 in the World

Stockholm, Sweden

Bioarctic Neuroscience Ab

Forward Citations = 159

30 inventors:

Lars Lannfelt (14 out of 17 patents)

Pär Gellerfors (8 out of 10 patents)

Alex Kasrayan (4 out of 4 patents)

4. Eva Nordström (4 out of 4 patents)

5. Monica Ekberg (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…